Uganda vs Western Sahara: Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology
Uganda
0.3%
in 2024
Western Sahara
0.3%
in 2024
Uganda rank
85th
Western Sahara rank
85th
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology over time
- Uganda
- Western Sahara
How they compare
Uganda currently reports 0.3% against 0.3% in Western Sahara, a difference of 0.0%.
The two have swapped places 1 time across 10 shared years of data; in 2015 it was Uganda ahead.
Uganda ranks 85th and Western Sahara ranks 85th of 246 countries.
Uganda has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Uganda | Western Sahara | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 0.4% | 0.2% | 0.2% | Uganda |
| 2020s | 0.4% | 0.2% | 0.2% | Uganda |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence of hepatitis b surface antigen (hbsag), 2026 methodology, Uganda or Western Sahara?
- Uganda, at 0.3% against 0.3% in Western Sahara as of 2024.
- What is the difference in prevalence of hepatitis b surface antigen (hbsag), 2026 methodology between Uganda and Western Sahara?
- 0.0%, with Uganda ahead.
- How many years of comparable data are there for Uganda and Western Sahara?
- 10 years are reported by both, from 2015 to 2024.
- How do Uganda and Western Sahara rank globally for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology?
- Uganda ranks 85th and Western Sahara ranks 85th of 246 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.